Silence Therapeutics plc Proceeds from Common Stock Issued
Silence Therapeutics plc (SLNCF) reported Proceeds from Common Stock Issued of $2.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-10
- Silence Therapeutics plc proceeds from issuance of common stock for the quarter ending 2026-06-30 was $2.00K, a 100.00% increase year-over-year.
- Silence Therapeutics plc proceeds from issuance of common stock for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Silence Therapeutics plc proceeds from issuance of common stock for the quarter ending 2025-12-31 was $0.00.
- Silence Therapeutics plc proceeds from issuance of common stock for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Silence Therapeutics plc proceeds from issuance of common stock for fiscal 2025 was $15.00K, a 99.99% decline from fiscal 2024.
- Silence Therapeutics plc proceeds from issuance of common stock for fiscal 2024 was $142.09M, a 344.90% increase from fiscal 2023.
- Silence Therapeutics plc proceeds from issuance of common stock for fiscal 2023 was $31.94M, a 39.26% decline from fiscal 2022.
- Silence Therapeutics plc proceeds from issuance of common stock for fiscal 2022 was $52.58M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $2.00K 10-Q · filed 2026-08-10 | $2.00K derived: sum of 3 quarters · filed 2026-08-10 | $2.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $1.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $1.00K derived: sum of 3 quarters · filed 2026-08-10 | $15.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.00K derived: sum of 2 quarters · filed 2026-08-10 | $15.00K 10-Q · filed 2025-11-06 | -$83.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $15.00K 10-Q · filed 2026-08-10 | -$83.00K derived: sum of 3 quarters · filed 2026-08-10 | $7.89M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $14.00K 10-Q · filed 2026-05-07 | -$84.00K derived: sum of 2 quarters · filed 2026-05-07 | $7.89M derived: sum of 3 quarters · filed 2026-05-07 | $9.08M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $7.87M derived: sum of 2 quarters · filed 2026-03-05 | $9.07M derived: sum of 3 quarters · filed 2026-03-05 | $142.09M 10-K · filed 2026-03-05 |
| 2024-09-30 | $7.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $9.16M derived: sum of 2 quarters · filed 2025-11-06 | $142.19M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $134.21M 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $133.02M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $31.94M 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $52.58M 10-K · filed 2025-02-27 |